8911 |
CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA1 I |
CACNA1I |
Cav3.3 |
ca(v)3.3 |
608230 |
1396 |
ENSG00000100346 |
OTTHUMG00000151096 |
Q9P0X4 |
VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1I |
CAC1I_HUMAN |
VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL ALPHA-1I SUBUNIT (VOLTAGE- GATED CALCIUM CHANNEL ALPHA SUBUNIT CAV3.3) (CA(V)3.3). [SOURCE:UNIPROT/SWISSPROT;ACC:Q9P0X4] |
KIAA1120 |
PA26011 |
Voltage-gated calcium channel subunit alpha Cav3.3 |
Interpro Acc | IPR005821 |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | Ion_trans_dom |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Domain |
Human Readable Name | ION CHANNEL |
Uniprot Status | Swiss-Prot |
Interpro Name | Ion transport domain |
Target Main Class | Transporters |
Target Subclass | Channels |
Transmembrane Helix Count | 23 |
Target Subclass | Voltage_gated_ion_channels |
Target Subclass | CalciumChannels |
Initial Gene Query | Cav3.3 |
Counted Citations from 1950-2000 | 149 |
Target Class | Transporters |
Target Subclass | TC:1.A.1.11.7 |
Gene Biotype | PROTEIN_CODING |
ION CHANNEL |
DRUGGABLE GENOME |
suppressor (inhibitory) |
blocker (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | Voltage-gated T-type calcium channel blocker |
inhibitor (inhibitory) |
Trial Name | Empatic |
Novel drug target | Established target |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated T-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated T-type calcium channel blocker |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated T-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated T-type calcium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated T-type calcium channel blocker |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated calcium channel blocker |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
modulator |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
CACNA1I | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
ENSG00000100346 | Ensembl Gene Id |
VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL ALPHA-1I SUBUNIT (VOLTAGE- GATED CALCIUM CHANNEL ALPHA SUBUNIT CAV3.3) (CA(V)3.3). [SOURCE:UNIPROT/SWISSPROT;ACC:Q9P0X4] | Description |
CACNA1I | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
CACNA1I | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:1.A.1.11.7 |
8911 | Entrez Gene ID |
Initial Gene Query | Cav3.3 |
Counted Citations from 1950-2000 | 149 |
ION CHANNEL |
CACNA1I | Uniprot Gene Name |
CAC1I_HUMAN | Uniprot Id |
8911 | Entrez Gene Id |
Interpro Acc | IPR005821 |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | Ion_trans_dom |
ION CHANNEL, DRUGGABLE GENOME |
ENSG00000100346 | Ensembl Gene Id |
8911 | Entrez Gene Id |
Q9P0X4 | Uniprot Accession |
Target Main Class | Transporters |
Target Subclass | Channels |
Transmembrane Helix Count | 23 |
PA26011 | PharmGKB ID |
ENSG00000100346 | Gene Symbol |
CACNA1I | Ensembl Id |
DRUGGABLE GENOME |
KIAA1120 | GENE_SYMBOL |
CACNA1I | GENE_SYMBOL |
Voltage-dependent T-type calcium channel subunit alpha-1I | UNIPROT |
Voltage-dependent T-type calcium channel subunit alpha-1I | Gene Name |
Q9P0X4 | UniProt ID |
ION CHANNEL |